Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,433 | 53 | 83.5% |
| Food and Beverage | $15,826 | 1,024 | 13.0% |
| Consulting Fee | $2,400 | 1 | 2.0% |
| Travel and Lodging | $1,340 | 7 | 1.1% |
| Education | $434.30 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $69,543 | 152 | $0 (2022) |
| ABBVIE INC. | $35,412 | 119 | $0 (2024) |
| EMD Serono, Inc. | $2,884 | 26 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,230 | 72 | $0 (2024) |
| LivaNova USA, Inc. | $797.16 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $794.18 | 68 | $0 (2022) |
| Biogen, Inc. | $727.24 | 37 | $0 (2024) |
| PFIZER INC. | $706.95 | 68 | $0 (2024) |
| UCB, Inc. | $639.32 | 30 | $0 (2024) |
| Lilly USA, LLC | $536.08 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,618 | 148 | ABBVIE INC. ($424.31) |
| 2023 | $9,477 | 144 | AbbVie Inc. ($5,059) |
| 2022 | $18,929 | 158 | ABBVIE INC. ($16,969) |
| 2021 | $41,957 | 151 | Allergan, Inc. ($27,509) |
| 2020 | $26,944 | 133 | Allergan, Inc. ($25,636) |
| 2019 | $18,229 | 126 | Allergan Inc. ($16,006) |
| 2018 | $1,522 | 122 | Allergan Inc. ($180.10) |
| 2017 | $1,756 | 112 | Teva Pharmaceuticals USA, Inc. ($213.01) |
All Payment Transactions
1,094 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.64 | General |
| 12/17/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Parkinson's Disease | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $36.65 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: PAIN | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN | ||||||
| 11/26/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.39 | General |
| Category: Neuropsychiatry | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $36.65 | General |
| 11/22/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Pain Management | ||||||
| 11/20/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Rare Disease | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 586 | 7,888 | $325,722 | $107,657 |
| 2022 | 12 | 529 | 8,920 | $318,040 | $104,493 |
| 2021 | 13 | 550 | 12,174 | $397,823 | $136,559 |
| 2020 | 14 | 594 | 10,917 | $314,180 | $125,115 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 7,145 | $92,885 | $35,313 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 126 | $43,218 | $15,474 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 137 | $34,798 | $10,959 | 31.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 26 | 26 | $23,489 | $7,785 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $24,960 | $7,362 | 29.5% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 37 | 38 | $21,318 | $7,315 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $23,616 | $7,261 | 30.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 28 | 28 | $19,656 | $5,322 | 27.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 41 | 61 | $13,298 | $4,294 | 32.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 16 | 36 | $12,420 | $3,310 | 26.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 13 | 13 | $7,930 | $2,354 | 29.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 83 | $7,470 | $815.28 | 10.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 45 | 83 | $664.00 | $92.37 | 13.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 8,300 | $107,900 | $40,585 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 201 | $51,054 | $15,496 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 87 | $29,990 | $9,472 | 31.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 31 | 31 | $28,954 | $9,397 | 32.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $22,140 | $6,658 | 30.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 29 | 29 | $20,358 | $5,772 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $19,500 | $5,516 | 28.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 49 | 64 | $13,952 | $4,617 | 33.1% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 19 | 20 | $11,220 | $3,817 | 34.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 15 | 15 | $9,150 | $2,744 | 30.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 39 | $3,510 | $370.27 | 10.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 28 | 39 | $312.00 | $47.27 | 15.2% |
About Dr. Disha Shah, MD
Dr. Disha Shah, MD is a Clinical Neurophysiology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1366671265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Disha Shah, MD has received a total of $121,433 in payments from pharmaceutical and medical device companies, with $2,618 received in 2024. These payments were reported across 1,094 transactions from 80 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,433).
As a Medicare-enrolled provider, Shah has provided services to 2,259 Medicare beneficiaries, totaling 39,899 services with total Medicare billing of $473,825. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Clinical Neurophysiology
- Location Louisville, KY
- Active Since 07/13/2009
- Last Updated 02/04/2014
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1366671265
Products in Payments
- BOTOX (Biological) $43,870
- UBRELVY (Drug) $41,431
- BOTOX (Drug) $15,819
- QULIPTA (Drug) $3,460
- NURTEC ODT (Drug) $1,040
- VNS Therapy (Device) $768.63
- APTIOM (Drug) $761.92
- TYSABRI (Biological) $486.89
- ZEPOSIA (Drug) $446.41
- TROKENDI XR (Drug) $391.77
- Hizentra (Biological) $318.58
- Briviact (Drug) $292.50
- EMGALITY (Drug) $285.29
- KESIMPTA (Drug) $283.61
- AJOVY (Biological) $240.56
- COPAXONE (Drug) $227.34
- Vimpat (Drug) $221.14
- NUPLAZID (Drug) $215.93
- Aimovig (Biological) $203.46
- Gamunex-C (Biological) $200.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Louisville
Dr. Thomas Rampy, M.d, M.D
Clinical Neurophysiology — Payments: $18,711
Dr. James Thompson, Md, MD
Clinical Neurophysiology — Payments: $1,150
Dr. Vasudeva Iyer, M.d, M.D
Clinical Neurophysiology — Payments: $69.03